This is the first paid-subscriber issue of The Biotech Tea ☕. Starting today, newsletters will alternate between issues that are free for everyone and issues exclusively for paid subscribers.
Let’s get into this week’s cup of biotech tea. ☕ If you only have time for one this week, I’d start with #5!
A glioblastoma vaccine narrowly misses success, but may still have hope ➡️
A logic-gated CAR-T therapy for renal cell carcinoma enters the clinic ➡️
NIH launches new website design focused on streamlining finding info➡️
FDA announces the Office of Innovation and Clinical Trial Modernization ➡️
Could cystic fibrosis treatment begin before birth? A family story ➡️
Biotech Term of the Week: Primary & Secondary Endpoints ➡️
🐝Stay tuned! I’m attending Utah’s Biohive Premieres today, so next week’s issue will be a special event-themed edition. Same structure, but sections pulled from presentations I attended!
